MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0011744
Velox Biologics Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.77 Cr
▲ 12% YoY
Net profit · FY 2025
₹1.54 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹7.2 Lakh
EBITDA margin 4.1%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹8.23 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Velox Biologics Private Limited
Data last updated:
Velox Biologics Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2011PTC032721. Its GSTIN is 04AADCV5446R1ZR (Chandigarh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Sumesh Kumar Sharma and Ashish Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 389 Ground Floor & Basement Motor Market And Commercial Complex Mani, Majra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.77 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹1.54 Lakh (net margin 0.9%) and EBITDA of ₹7.2 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 2% over five years.
The company is associated with 1 brand: Velox Biologics. As per MCA filings, the company has open charges of ₹8.23 Lakh on record.
Velox Biologics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0011744). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website veloxbiologics.com.
Company details
CIN U24232CH2011PTC032721
Registration Number 032721
Incorporation Date 04 February 2011
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0011744
Recognitions & Rankings of Velox Biologics
Contact details
Velox Biologics Private Limited's registered office is in Chandigarh, Chandigarh. Its website is veloxbiologics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressScf 389 Ground Floor & Basement Motor Market And Commercial Complex Mani, Majra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Velox Biologics Private Limited, buy the company report.
Comprehensive company report
Velox Biologics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Velox Biologics operates one associated brand: Velox Biologics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Velox Biologics manufactures and markets pharmaceutical drugs and offers franchise services. | veloxbiologics.com |
Business activity
The main business activity of Velox Biologics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Velox Biologics Private Limited, buy the company report.
Financials of Velox Biologics Private Limited
FY 2025 filings availableVelox Biologics Private Limited reported revenue of ₹1.77 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹1.77 Cr ▲ 12%
Net profit · FY 2025
₹1.54 Lakh margin 0.9%
EBITDA · FY 2025
₹7.2 Lakh margin 4.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 9%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 12% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Velox Biologics Private Limited, buy the company report.
Board of directors of Velox Biologics Private Limited
Velox Biologics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumesh Kumar Sharma Also directs: Cinerea Biotech Private Limited | Director | 04 Feb 2011 | 15 Years 9 Months | Current |
| Ashish Sharma | Director | 28 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Velox Biologics Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Biologics, Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nova Biopharma Private Limited | ₹1.78 Cr (FY 2025) | 8.0% | Jodhpur, Rajasthan, India | |||
| Ontime Globe Kyarrier Private Limited | ₹1.77 Cr (FY 2021) | 12018.0% | Pune, Maharashtra, India | |||
| Velox Biologics Private Limitedthis company | ₹1.77 Cr (FY 2025) | ₹1.54 Lakh | 0.9% | 12.0% | Chandigarh, India | |
| Stoicure Pharmaceuticals Private Limited | ₹1.76 Cr (FY 2024) | 432.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Velox Biologics Private Limited, buy the company report.
Auditor
Velox Biologics Private Limited is audited by AMIT K SHARMA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT K SHARMA & ASSOCIATES | FY 2023 | 021287N |
Shareholding
The shareholding of Velox Biologics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Velox Biologics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.23 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Feb 2017 | 100095145 | Others | ₹8.23 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Velox Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Velox Biologics Private Limited has 3 MSME Form 1 returns on record for the period ending Mar 2019, listing 39 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ultra Drugs Private Limited | |||
| Legen Healthcare | |||
| an individual supplier | |||
| Elnova Pharma |
To see the full MSME payment records of Velox Biologics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Velox Biologics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AADCV5446R1ZR | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Velox Biologics Private Limited, buy the company report.
Recent activity
Velox Biologics Private Limited has 5 board changes on record since 2011: 2 appointments and 3 cessations. The latest: Ashish Sharma was appointed as Director on 28 Jan 2021.
AGM
Velox Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Velox Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Ashish Sharma was appointed as Director.
Ceased
Vikas Sharma ceased to be Director Appointed In Casual Vacancy.
Ceased
Prikshat Kumar Sharma ceased to be Director.
Charges
A charge with Others amounted to Rs. 8.23 Lakh with Charge ID 100095145 was registered on 06 Feb 2017.
Ceased
Anuradha Prikshat Kumar ceased to be Director.
Appointed
Sumesh Kumar Sharma was appointed as Director.
Incorporation
04 Feb 2011
Velox Biologics Private Limited was registered on 04 Feb 2011 with Roc Chandigarh & aged 15 years 9 months as per MCA records.
Frequently asked questions
Velox Biologics is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2011 (15+ years old) and is registered under CIN U24232CH2011PTC032721.
Velox Biologics has 2 current directors:
- Sumesh Kumar Sharma - Director
- Ashish Sharma - Director
The latest financial statements of Velox Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Velox Biologics is 04AADCV5446R1ZR, registered in Chandigarh.
The CIN (Corporate Identification Number) of Velox Biologics is U24232CH2011PTC032721. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Velox Biologics was incorporated on 04 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Velox Biologics by revenue are Nova Biopharma Private Limited, Ontime Globe Kyarrier Private Limited, Stoicure Pharmaceuticals Private Limited, all in the Pharma industry (Biologics, Formulations), with the same principal business activity (wholesale trading).
Ashish Sharma was appointed as Director on 28 Jan 2021. Vikas Sharma ceased to be Director Appointed In Casual Vacancy on 05 Dec 2018. Prikshat Kumar Sharma ceased to be Director on 29 Nov 2018. Velox Biologics has 5 board changes on record in total.
Yes, Velox Biologics is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0011744).
Velox Biologics has 3 MSME Form 1 returns on record for the period ending Mar 2019, listing 39 overdue payments to 4 micro and small suppliers. The latest return was filed on 18 Jun 2019.
Velox Biologics can be reached through the website veloxbiologics.com. Its registered office is in Chandigarh, India.
The registered office of Velox Biologics is at Scf 389 Ground Floor & Basement Motor Market And Commercial Complex Mani, Majra, Chandigarh, India – 160101.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages